Javascript must be enabled to continue!
Identification Of Immune Networks Influenced By Mir-200c In IDH1-Mutant Lower-Grade Gliomas Using WGCNA
View through CrossRef
Abstract
Gliomas are the most common intracranial tumors with a highly invasive nature and poor prognosis. Different stages of gliomas have distinct alterations in genome, genetic and epigenetic changes. Here, we performed enrichment analysis and weighted gene correlation network analysis (WGCNA) on the Cancer Genome Atlas (TCGA) RNA-seq dataset to identify core genes and potential pathways involved in Isocitrate Dehydrogenase 1 (IDH1) mutant lower-grade gliomas (LGG). The IDH1-mutant LGG patients were found to frequently co-occur with abundant genetic alterations, surprisingly, the miR-200c/141 remain unchanged. Although located in close proximity, the expression level of miR-200c was more affected by methylation level and copy number variation than that of miR-141 in IDH1-mutant LGG. GO analysis indicated the high correlation between miR-200c and immune response. Gene set enrichment analysis (GSEA) suggested that leukocyte activation, inflammatory response, lymphocyte activation and adaptive immune response were significantly up-regulated in miR-200c high-expression group. Enrichment analysis demonstrated that leukocyte activation, immune response, lymphocyte proliferation, cell-cell adhesion and other items were participants in IDH1-mutant LGG samples. Furthermore, WGCNA yielded 33 significant modules, including the yellow module which contains genes involved in the immune response. Taken together, these results proposed a promising new therapeutic strategy for treating LGG gliomas through a miR-200c-mediated immune response pathway.
Title: Identification Of Immune Networks Influenced By Mir-200c In IDH1-Mutant Lower-Grade Gliomas Using WGCNA
Description:
Abstract
Gliomas are the most common intracranial tumors with a highly invasive nature and poor prognosis.
Different stages of gliomas have distinct alterations in genome, genetic and epigenetic changes.
Here, we performed enrichment analysis and weighted gene correlation network analysis (WGCNA) on the Cancer Genome Atlas (TCGA) RNA-seq dataset to identify core genes and potential pathways involved in Isocitrate Dehydrogenase 1 (IDH1) mutant lower-grade gliomas (LGG).
The IDH1-mutant LGG patients were found to frequently co-occur with abundant genetic alterations, surprisingly, the miR-200c/141 remain unchanged.
Although located in close proximity, the expression level of miR-200c was more affected by methylation level and copy number variation than that of miR-141 in IDH1-mutant LGG.
GO analysis indicated the high correlation between miR-200c and immune response.
Gene set enrichment analysis (GSEA) suggested that leukocyte activation, inflammatory response, lymphocyte activation and adaptive immune response were significantly up-regulated in miR-200c high-expression group.
Enrichment analysis demonstrated that leukocyte activation, immune response, lymphocyte proliferation, cell-cell adhesion and other items were participants in IDH1-mutant LGG samples.
Furthermore, WGCNA yielded 33 significant modules, including the yellow module which contains genes involved in the immune response.
Taken together, these results proposed a promising new therapeutic strategy for treating LGG gliomas through a miR-200c-mediated immune response pathway.
Related Results
Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model
Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model
Abstract
Mutations in isocitrate dehydrogenase (IDH) 1 and 2 are frequently observed in acute myeloid leukemia (AML), glioma, and many other cancers. While wild-type...
BIOM-17. DIFFERENCES IN THE IMMUNE MICROENVIRONMENT OF GLIOMAS HARBORING IDH2 VERSUS IDH1 MUTATIONS
BIOM-17. DIFFERENCES IN THE IMMUNE MICROENVIRONMENT OF GLIOMAS HARBORING IDH2 VERSUS IDH1 MUTATIONS
Abstract
INTRODUCTION
IDH mutations are a defining feature of lower-grade glioma and secondary glioblastoma. Approximately 95% o...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
AbstractMicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is involved in liver disea...
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression
The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression
This study was aimed to investigate the function and mechanism of microRNA-200c (miR-200c) in the progression of non-small cell lung cancer (NSCLC). A total of 76 patients diagnose...
ANGI-15. IDH1 R132H MUTATION IMPAIRS GLIOMA INVASIVENESS THROUGH EPIGENETIC REPRESSION OF MMP2 IN EXPERIMENTAL MODELS AND HUMAN GBMS
ANGI-15. IDH1 R132H MUTATION IMPAIRS GLIOMA INVASIVENESS THROUGH EPIGENETIC REPRESSION OF MMP2 IN EXPERIMENTAL MODELS AND HUMAN GBMS
Abstract
Glioblastoma (GBM) is a highly diffusive tumor which restricts the efficacy of surgical resection and facilitates tumor recurrence. Matrix metalloprotein...
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression
Abstract
Background: Breast cancer (BC) is one of the most common cancers worldwide and is associated with a high rate of cancer mortality in women. Resistance to chemother...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...

